https://www.selleckchem.com/pr....oducts/ademetionine.
6-fold higher in the highest-risk group than in the lowest group (p  less then  0.001). Compared with a clinical model (global chi-square = 69.6), LVEF, AVs, and both of them were significantly improved outcome prediction in sequential Cox model analysis (global chi-square = 75.6, 75.7, and 78.8, respectively; p  less then  0.05 for each) for each. In patients with AIS, LVEF  less then  62%, and the presence of AV sclerosis can predict future vascular events. Patients with AIS exhibiting reduced LVEF and AV sclerosis may benefit fr